A review on the role of Phytosterols: New insights into cardiovascular risk

Current Pharmaceutical Design

Volumn 17, Issue 36, 2011, Pages 4061-4075

  Rocha, Milagros ^a,b   Bañuls, Celia ^a   Bellod, Lorena ^a   Jover, Ana ^a   Víctor, Víctor M ^a,b   Hernández Mijares, Antonio ^a,b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Apolipoprotein E; Cardiovascular risk; Carotenoids; Hypercholesterolemia; LDL cholesterol; Phytosterols

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CAMPESTANOL; CAMPESTEROL; CAROTENOID; CHOLESTEROL; PHYTOSTEROL; SITOSTANOL; SITOSTEROL; STIGMASTEROL; VITAMIN;

APOPTOSIS; CANCER INHIBITION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; DIET; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; DRUG USE; HUMAN; LIPID ABSORPTION; METABOLIC SYNDROME X; NONHUMAN; PHYTOSTEROLEMIA; PRIORITY JOURNAL; REVIEW; SITOSTEROLEMIA;

EID: 84855234056     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211798764852     Document Type: Review

References (172)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 2010; 121: 948-54.
2. Miettinen TA, Gylling H. Plant stanol and sterol esters in prevention of cardiovascular diseases. Ann Med 2004; 36: 126-34.
3. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006; 295: 1556-65.
4. Florentin M, Liberopoulos EN, Mikhailidis DP, Elisaf MS. Fibrate associated adverse effects beyond muscle and liver toxicity. Curr Pharm Des 2008; 14: 574-87.
5. Kiortsis DN, Filippatos TD, Mikhailidis DP, Elisaf MS, Liberopoulos EN. Statin associated adverse effects beyond muscle and liver toxicity. Atherosclerosis 2007; 195: 7-16.
6. Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Car-diovasc Drugs 2008; 8: 373-418.
7. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Circulation 2004; 110: 227-39.
8. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007; 28: 2375-414.
9. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
10. Quílez J, García-Lorda P, Salas-Salvadó J. Potential uses and benefits of phytosterols in diet: present situation and future directions. Clin Nutr 2003; 22: 343-51.
11. Jandacek RJ, Webb MR, Mattson FH. Effect of an aqueous phase on the solubility of cholesterol in an oil phase. J Lipid Res 1977; 18: 203-10.
12. Demonty I, Ras RT, van der Knaap HC, et al. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr 2009; 139: 271-84.
13. Ostlund RE Jr. Phytosterols in human nutrition. Annu Rev Nutr 2002; 22: 533-49.
14. Jiménez-Escrig A, Santos-Hidalgo AB, Saura-Calixto F. Common sources and estimated intake of plant sterols in the Spanish diet. J Agric Food Chem 2006; 54: 3462-71.
15. Hasler, CM. Functional foods: Benefits, concerns and callenges-a position paper from the american council on science and health. J Nutr 2002; 132: 3772-81.
16. Plat J, Kerckhoffs DA, Mensink RP. Therapeutic potential of plant sterols and stanols. Curr Opin Lipidol 2000; 11: 571-6.
17. de Jong A, Plat J, Mensink RP. Metabolic effects of plant sterols and stanols. J Nutr Biochem 2003; 14: 362-9.
18. Plat J, Mensink RP. Plant stanol and sterol esters in the control of blood cholesterol levels: mechanism and safety aspects. Am J Car-diol 2005; 96 (1A): 15D-22.
19. von Bergmann K, Sudhop T, Lutjohann D. Cholesterol and Plant Sterol Absorption: Recent Insights. Am J Cardiol 2005; 96 (1A): 10D-14D.
20. Salen G, Ahrens Jr EH, Grundy SM. Metabolism of beta-sitosterol in man. J Clin Invest 1970; 49: 952-67.
21. Ostlund RE, Jr., McGill JB, Zeng CM, et al. Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phy-tostanols in humans. Am J Physiol Endocrinol Metab 2002; 282: E911-6.
22. Davis HR Jr, Altmann SW. Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter. Biochim Biophys Acta 2009; 1791: 679-83.
23. Sudhop T, Lutjohann D, von Bergmann K. Sterol transporters: targets of natural sterols and new lipid lowering drugs. Pharmacol Ther 2005; 105: 333-41.
24. Sudhop T, Gottwald BM, von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism 2002; 51: 1519-21.
25. Chan YM, Varady KA, Lin Y, et al. Plasma concentrations of plant sterols: physiology and relationship with coronary heart disease. Nutr Rev 2006; 64: 385-402.
26. Hallikainen MA, Sarkkinen ES, Gylling H, Erkkilä AT, Uusitupa MI. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr 2000; 54: 715-25.
27. Weststrate JA, Meijer GW. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1998; 52: 334-43.
28. Calpe-Berdiel L, Escolà-Gil JC, Blanco-Vaca F. New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis 2009; 203: 18-31.
29. Awika JM, Rooney LW. Sorghum phytochemicals and their potential impact on human health. Phytochemistry 2004; 65: 1199-221.
30. Weststrate JA, Ayesh R, Bauer-Plank C, Drewitt PN. Safety evaluation of phytosterol esters. Part 4. Faecal concentrations of bile acids and neutral sterols in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. Food Chem Toxicol 1999; 37: 1063-71.
31. Plat J, Mensink RP. Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear blood cells of healthy men and women. FASEB J. 2002; 16: 258-60.
32. Jones PJ, Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 2000; 41: 697-705.
33. Robins SJ, Fasulo JM. High density lipoproteins, but not other lipoproteins, provide a vehicle for sterol transport to bile. J Clin Invest 1997; 99: 380-4.
34. Miettinen TA, Vuoristo M, Nissinen M, Jarvinen HJ, Gylling H. Serum, biliary, and fecal cholesterol and plant sterols in colec-tomized patients before and during consumption of stanol ester margarine. Am J Clin Nutr 2000; 71: 1095-102.
35. Lee MH, Lu K, Hazard S, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001; 27: 79-83.
36. Richelle M, Enslen M, Hager C, et al. Both free and esterified plant sterols reduce cholesterol absorption and the bioavailability of beta-carotene and alpha-tocopherol in normocholesterolemic humans. Am J Clin Nutr 2004; 80: 171-7.
37. Klingberg S, Ellegard L, Johansson I, et al. Inverse relation between dietary intake of naturally occurring plant sterols and serum cholesterol in northern Sweden. Am J Clin Nutr 2008; 87: 993-1001.
38. Ostlund RE, Racette SB, Stenson WF. Inhibition of cholesterol absorption by phytosterol-replete wheat germ compared with phy-tosterol-depleted wheat germ. Am J Clin Nutr 2003; 77: 1385-9.
39. Lin X, Racette SB, Lefevre M, et al. The effects of phytosterols present in natural food matrices on cholesterol metabolism and LDL-cholesterol: a controlled feeding trial. Eur J Clin Nutr 2010; 64: 1481-7.
40. Racette SB, Lin X, Lefevre M, et al. Dose effects of dietary phytos-terols on cholesterol metabolism: a controlled feeding study. Am J Clin Nutr 2009; 91: 32-8.
41. Katan MB, Grundy SM, Jones P, et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003; 78: 965-78.
42. Law M. Plant sterol and stanol margarines and health. BMJ 2000; 320: 861-4.
43. Ellegard LH, Andersson SW, Normen AL, Andersson HA. Dietary plant sterols and cholesterol metabolism. Nutr Rev 2007; 65: 39-45.
44. Van Horn L, McCoin M, Kris-Etherton PM, et al. The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc 2008; 108: 287-331.
45. Moruisi KG, Oosthuizen W, Opperman AM. Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. J Am Coll Nutr 2006; 25: 41-8.
46. Chen JT, Wesley R, Shamburek RD, Pucino F, Csako G. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy 2005; 25: 171-83.
47. Musa-Veloso K, Poon TH, Elliot JA, Chung C. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results of a meta-analysis of randomized, placebo-controlled trials. Prostaglandins Leukot Es-sent Fatty Acids 2011; 85: 9-28.
48. Hendriks HF, Weststrate JA, van Vliet T, Meijer GW. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1999; 53: 319-27.
49. Pelletier X, Belbraouet S, Mirabel D, et al. A diet moderately enriched in phytosterols lowers plasma cholesterol concentrations in normocholesterolemic humans. Ann Nutr Metab 1995; 39: 291-5.
50. Sierksma A, Weststrate JA, Meijer GW. Spreads enriched with plant sterols, either esterified 4, 4-dimethylsterols or free 4-desmethylsterols, and plasma total- and LDL-cholesterol concentrations. Br J Nutr 1999; 82: 273-82.
51. AbuMweis SS, Barake R, Jones P. Plant sterols/stanols as cholesterol lowering agents: A meta-analysis of randomized controlled trials. Food Nutr Res 2008; 52; doi: 10.3402/fnr.v52i0.1811.
52. Naumann E, Plat J, Kester AD, Mensink RP. The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations. J Am Coll Nutr 2008; 27: 117-26.
53. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum-cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 1995; 333: 1308-12.
54. Hallikainen MA, Uusitupa MI. Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr 1999; 69: 403-10.
55. Christiansen LI, Lähteenmäki PL, Mannelin MR, Seppänen-Laakso TE, Hiltunen RV, Yliruusi JK. Cholesterol-lowering effect of spreads enriched with microcrystalline plant sterols in hypercholes-terolemic subjects. Eur J Nutr 2001; 40: 66-73.
56. Amundsen AL, Ntanios F, Put N, Ose L. Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread. Eur J Clin Nutr 2004; 58: 1612-20.
57. Hendriks HF, Brink EJ, Meijer GW, Princen HM, Ntanios FY. Safety of long-term consumption of plant sterol esters-enriched spread. Eur J Clin Nut 2003; 57: 681-92.
58. Gylling H, Hallikainen M, Raitakari OT, et al. Long-term consumption of plant stanol and sterol esters, vascular function and genetic regulation. Br J Nutr 2009; 101: 1688-95.
59. De Jong A, Plat J, Lutjohann D, Mensink RP. Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment. Br J Nutr 2008; 100: 937-41.
60. Wolfs M, de Jong N, Ocke MC, Verhagen H, Monique Verschuren WM. Effectiveness of customary use of phytosterol/-stanol enriched margarines on blood cholesterol lowering. Food Chem Toxicol 2006; 44: 1682-8.
61. Plat J, van Onselen EN, van Heugten MM, Mensink RP. Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr 2000; 54: 671-7.
62. AbuMweis SS, Vanstone CA, Lichtenstein AH, Jones PJ. Plant sterol consumption frequency affects plasma lipid levels and cholesterol kinetics in humans. Eur J Clin Nutr 2009; 63: 747-55.
63. Matvienko OA, Lewis DS, Swanson M, et al. A single daily dose of soybean phytosterols in ground beef decreases serum total cholesterol and LDL cholesterol in young, mildly hypercholes-terolemic men. Am J Clin Nutr 2002; 76: 57-64.
64. Plana N, Nicolle C, Ferre R, et al. Plant sterol-enriched fermented milk enhances the attainment of LDL-cholesterol goal in hypercho-lesterolemic subjects. Eur J Nutr 2008; 47: 32-9.
65. Algorta Pineda J, Chinchetru Ranedo MJ, Aguirre Anda J, Francisco Terreros S. Hypocholesteremic effectiveness of a yogurt containing plant stanol esters. Rev Clin Esp 2005; 205: 63-6.
66. AbuMweis SS, Vanstone CA, Ebine N, et al. Intake of a single morning dose of standard and novel plant sterol preparations for 4 weeks does not dramatically affect plasma lipid concentrations in humans. J Nutr 2006; 136: 1012-6.
67. Cella LK, Vancauter E, Schoeller DA. Effect of meal timing on diurnal rhythm of human cholesterol synthesis. Am J Physiol-Endocrinol Metab 1995; 32: E878-83.
68. Galman C, Angelin B, Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology 2005; 129: 1445-53.
69. Miettinen TA, Gylling H. Plant stanol and sterol esters in prevention of cardiovascular diseases: a review. Int J Clin Pharmacol Ther 2006; 44: 247-50.
70. Vanstone CA, Raeini-Sarjaz M, Parsons WE, Jones PJ. Unesteri-fied plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons. Am J Clin Nutr 2002; 76: 1272-8.
71. Talati R, Sobieraj DM, Makanji SS, Phung OJ, Coleman CI. The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis. J Am Diet Assoc 2010; 110: 719-26.
72. Nguyen TT. The cholesterol-lowering action of plant stanol esters. J Nutr 1999; 129: 2109-12.
73. O'Neill FH, Sanders TAB, Thompson GR. Comparison of Efficacy of Plant Stanol Ester and Sterol Ester: Short-Term and Longer-Term Studies. Am J Cardiol 2005; 96: 29-36.
74. Hernández-Mijares A, Bañuls C, Rocha M, et al. Effects of phytos-terol ester-enriched low-fat milk on serum lipoprotein profile in mildly hypercholesterolaemic patients are not related to dietary cholesterol or saturated fat intake. Br J Nutr 2010; 104: 1018-25.
75. Chen SC, Judd JT, Kramer M, Meijer GW, Clevidence BA, Baer DJ. Phytosterol intake and dietary fat reduction are independent and additive in their ability to reduce plasma LDL cholesterol. Lip-ids 2009; 44: 273-81.
76. Clifton PM, Noakes M, Ross D, Fassoulakis A, Cehun M, Nestel P. High dietary intake of phytosterol esters decreases carotenoids and increases plasma plant sterol levels with no additional cholesterol lowering. J Lipid Res 2004; 45: 1493-9.
77. Goldberg AC, Ostlund RE Jr, Bateman JH, Schimmoeller L, McPherson TB, Spilburg CA. Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs. Am J Cardiol 2006; 97: 376-9.
78. McPherson TB, Ostlund RE, Goldberg AC, Bateman JH, Schim-moeller L, Spilburg CA. Phytostanol tablets reduce human LDL-cholesterol. J Pharm Pharmacol 2005; 57: 889-96.
79. Acuff R, Cai D, Dong Z-P, Bell D. The lipid lowering effect of plant sterol ester capsules in hypercholesterolemic subjects. Lipids Health Dis 2007; 6: 11.
80. Earnest CP, Mikus CR, Lemieux I, Arsenault BJ, Church TS. Examination of encapsulated phytosterol ester supplementation on lipid indices associated with cardiovascular disease. Nutrition 2007; 23: 625-33.
81. Hayes KC, Pronczuk A, Wijendran V, Beer M. Free phytosterols effectively reduce plasma and liver cholesterol in gerbils fed cholesterol. J Nutr 2002; 132: 1983-8.
82. Maki KC, Davidson MH, Umporowicz DM, et al. Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr 2001; 74: 33-43.
83. Devaraj S, Jialal I, Vega-Lopez S. Plant sterol-fortified orange juice effectively lowers cholesterol levels in mildly hypercholes-terolemic healthy individuals. Arterioscler Thromb Vasc Biol 2004; 24: e25-8.
84. Quílez J, Rafecas M, Brufau G, et al. Bakery products enriched with phytosterol esters, alpha-tocopherol and beta-carotene decrease plasma LDL-cholesterol and maintain plasma beta-carotene concentrations in normocholesterolemic men and women. J Nutr 2003; 133: 3103-9.
85. Denke MA. Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hyper-cholesterolemia. Am J Clin Nutr 1995; 61: 392-6.
86. Mussner MJ, Parhofer KG, von Bergmann K, Schwandt P, Broedl U, Otto C. Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake. Metabolism 2002; 51: 189-94.
87. Kassis AN, Vanstone CA, AbuMweis SS, Jones PJ. Efficacy of plant sterols is not influenced by dietary cholesterol intake in hy-percholesterolemic individuals. Metabolism 2008; 57, 339-46.
88. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-30.
89. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipopro-tein E Alleles and Risk of Coronary Disease: A Meta-analysis. Ar-terioscler Thromb Vasc Biol 1996; 16: 1250-5.
90. Schaefer EJ, Lamon-Fava S, Johnson S, et al. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler Thromb 1994; 14: 1105-13.
91. Howard BV, Gidding SS, Liu K. Association of Apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults: The CARDIA Study. Am J Epidemiol 1998; 148: 859-68.
92. Plat J, Mensik RP. Relationship of genetic variation in genes encoding apolipoprotein A-IV scavenger receptor BI, HMG-CoA re-ductase, CETP and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption. Eur J Clin Invest 2002; 32: 242-50.
93. Nissinen MJ, Gylling H, Miettinen TA. Effects of dietary cholesterol and fat on serum non-cholesterol sterols according to different apolipoprotein E subgroups among healthy men. Br J Nutr 2008; 100: 373-9.
94. Ordovas JM. Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention. Am J Clin Nutr 2009; 89: 1509S-17S.
95. Vanhanen HT, Blomqvist S, Ehnholm C, et al. Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J Lipid Res 1993; 34: 1535-44.
96. Miettinen TA, Vanhanen H. Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipo-protein E phenotypes. Atherosclerosis 1994; 105: 217-26.
97. Sanchez-Muñiz FJ, Maki KC, Schaefer EJ, Ordovas JM. Serum lipid and antioxidant responses in hypercholesterolemic men and women receiving plant sterols vary by apolipoprotein E genotype. J Nutr 2009; 139: 13-9.
98. Geelen A, Zock PL, de Vries JH, Katan MB. Apolipoprotein E polymorphism and serum lipid response to plant sterols in humans. Eur J Clin Invest 2002; 32: 738-42.
99. Ishiwata K, Homma Y, Ishikawa T, Nakamura H, Handa S. Influence of apolipoprotein E phenotype on metabolism of lipids and apolipoproteins after plant stanol ester ingestion in Japanese subjects. Nutrition 2002; 18: 561-5.
100. Bañuls C, Martínez-Triguero ML, López-Ruiz A, et al. Serum lipid responses to phytosterol-enriched milk in a moderate hypercholes-terolemic population is not affected by apolipoprotein E polymorphism or diameter of low-density lipoprotein particles. Eur J Clin Nutr 2011; 65: 255-61.
101. Naumann E, Plat J, Mensink RP. Changes in serum concentrations of noncholesterol sterols and lipoproteins in healthy subjects do not depend on the ratio of plant sterols to stanols in the diet. J Nutr 2003; 133: 2741-7.
102. Wu T, Fu J, Yang Y, Zhang L, Han J. The effects of phytoster-ols/stanols on blood lipid profiles: a systematic review with meta-analysis, Asia Pac J Clin Nutr 2009; 18: 179-86.
103. Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990; 131: 20-31.
104. Tilvis RS, Miettinen TA. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 1986; 43: 92-7.
105. Gylling H, Miettinen TA. Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients. Atherosclerosis 2002; 160: 477-81.
106. Miettinen TA, Gylling H, Strandberg T, Sarna S. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators. BMJ 1998; 316: 1127-30.
107. Thuluva SC, Igel M, Giesa U, Lütjohann D, Sudhop T, von Berg-mann K. Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine. Int J Clin Pharmacol Ther 2005; 43: 305-10.
108. Fuentes F, López-Miranda J, García A, et al. Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia. Eur J Clin Nutr 2008; 62: 495-501.
109. Houweling AH, Vanstone CA, Trautwein EA, Duchateau GS, Jones PJ. Baseline plasma plant sterol concentrations do not predict changes in serum lipids, C-reactive protein (CRP) and plasma plant sterols following intake of a plant sterol-enriched food. Eur J Clin Nutr 2009; 63: 543-51.
110. Berge KE, von Bergmann K, Lutjohann D, et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 2002; 43: 486-94.
111. Gylling H, Hallikainen M, Nissinen MJ, Simonen P, Miettinen TA. Very high plant stanol intake and serum plant stanols and non-cholesterol sterols. Eur J Nutr 2010; 49: 111-7.
112. Pihlajamäki J, Gylling H, Miettinen TA, Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 2004; 45: 507-12.
113. Ooi EM, Ng TW, Chan DC, Watts GF. Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes. Diabetes Res Clin Pract 2009; 85: 310-6.
114. Simonen P, Gylling H, Howard AN, Miettinen TA. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 2000; 72: 82-8.
115. Gylling H, Hallikainen M, Kolehmainen M, et al. Cholesterol synthesis prevails over absorption in metabolic syndrome. Transl Res 2007; 149: 310-6.
116. [116] Hernández-Mijares A, Bañuls C, Jover A, et al. Low intestinal cholesterol absorption is associated with reduced efficacy of phy-tosterols esters as a hypolipemic agent in patients with metabolic syndrome. Clin Nutr 2011 (in press).
117. Ooi EM, Watts GF, Barrett PH, et al. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome. Asia Pac J Clin Nutr 2007; 16: 624-31.
118. Plat J, Brufau G, Dallinga-Thie GM, Dasselaar M, Mensink RP. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J Nutr 2009; 139: 1143-9.
119. Lerman RH, Minich DM, Darland G, et al. Subjects with elevated LDL cholesterol and metabolic syndrome benefit from supplementation with soy protein, phytosterols, hops rho iso-alpha acids, and Acacia nilotica proanthocyanidins. J Clin Lipidol 2010; 4: 59-68.
120. ialvera TE, Pounis GD, Koutelidakis AE, et al. Phytosterols supplementation decreases plasma small and dense LDL levels in metabolic syndrome patients on a westernized type diet. Nutr Me-tab Cardiovasc Dis 2011 (in press).
121. [121] Judd JT, Baer DJ, Chen SC, et al. Plant sterol esters lower plasma lipids and most carotenoids in mildly hypercholesterolemic adults. Lipids 2002; 37: 33-42.
122. Noakes M, Clifton P, Ntanios F, Shrapnel W, Record I, McInerney J. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr 2002; 75: 79-86.
123. Polagruto JA, Wang-Polagruto JF, Braun MM, Lee L, Kwik-Uribe C, Keen CL. Cocoa flavanol-enriched snack bars containing phytosterols effectively lower total and low-density lipoprotein choles terol levels. J Am Diet Assoc 2006; 106: 1804-13.
124. Volpe R, Niittynen L, Korpela R, et al. Effects of yoghurt enriched with plant sterols on serum lipids in patients with moderate hyper-cholesterolaemia. Br J Nutr 2001; 86: 233-9.
125. Colgan HA, Floyd S, Noone EJ, Gibney MJ, Roche HM. Increased intake of fruit and vegetables and a low-fat diet, with and without low-fat plant sterol-enriched spread consumption: effects on plasma lipoprotein and carotenoid metabolism. J Hum Nutr Diet 2004; 17: 561-9.
126. Thomsen AB, Hansen HB, Christiansen C, Green H, Berger A. Effect of free plant sterols in low-fat milk on serum lipid profile in hypercholesterolemic subjects. Eur J Clin Nutr 2004; 58: 860-70.
127. Korpela R, Tuomilehto J, Högström P, et al. Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols. Eur J Clin Nutr 2006; 60: 633-42.
128. Nestel P, Cehun M, Pomeroy S, Abbey M, Weldon G. Cholesterol-lowering effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods. Eur J Clin Nutr 2001; 55: 1084-90.
129. Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Jones PJH. No changes in serum fat-soluble vitamin and carotenoid concentrations with the intake of plant sterol/stanol esters in the context of a controlled diet. Metabolism 2002; 51: 625-56.
130. Hansel B, Nicolle C, Lalanne F, et al. Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxida-tive stress in moderate hypercholesterolemia. Am J Clin Nutr 2007; 86: 790-6.
131. Gylling H, Puska P, Vartiainen E, Miettinen TA.Retinol, Vitamin D, carotenes and alpha-tocopherol in serum of a moderately hyper-cholesterolemic population consuming sitostanol ester margarine. Atherosclerosis 1999; 145: 279-85.
132. Mensink RP, Ebbing S, Lindhout M, Plat J, van Heugten MM. Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble anti-oxidant concentrations. Atherosclerosis 2002; 160: 205-13.
133. Borel P, Grolier P, Armand M, et al. Carotenoids in biological emulsions: solubility, surface-to-core distribution, and release from lipid droplets. J Lipid Res 1996; 37: 250-61.
134. Brufau G, Quílez J, Angel Canela M, Salas-Salvadó J, Bulló MM, Rafecas M. Evaluation of lipid oxidation after ingestion of bakery products enriched with phytosterols, beta-carotene and alpha-tocopherol. Clin Nutr 2004; 23: 1390-7.
135. Ntanios FY, Duchateau GS. A healthy diet rich in carotenoids is effective in maintaining normal blood carotenoid levels during the daily use of plant sterol-enriched spreads. Int J Vitam Nutr Res 2002; 72: 32-9.
136. Devaraj S, Autret BC, Jialal I. Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers. Am J Clin Nutr 2006; 84: 756-61.
137. Bañuls C, Martínez-Triguero ML, López-Ruiz A, et al. Evaluation of cardiovascular risk and oxidative stress parameters in hypercho-lesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols. J Nutr Biochem 2010; 21: 881-6.
138. Davidson MH, Maki KC, Umporowicz DM, et al. Safety and toler-ability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women. J Am Coll Nutr 2001; 20: 307-19.
139. Berge KE. Sitosterolemia: a gateway to new knowledge about cholesterol metabolism. Ann Med 2003; 35: 502-11.
140. Salen G, Horak I, Rothkopf M, et al. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitos-terolemia with xanthomatosis. J Lipid Res 1985; 26: 1126-33.
141. Miettinen TA. Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur J Clin Invest 1980; 10: 27-35.
142. Mymin D, Wang J, Frohlich J, Hegele RA. Image in cardiovascular medicine. Aortic xanthomatosis with coronary ostial occlusion in a child homozygous for a nonsense mutation in ABCG8. Circulation 2003; 107: 791.
143. Su Y, Wang Z, Yang H, et al. Clinical and molecular genetic analysis of a family with sitosterolemia and co-existing erythrocyte and platelet abnormalities. Haematologica 2006; 91: 1392-5.
144. Patel MD, Thompson PD. Phytosterols and vascular disease. Atherosclerosis 2006; 186: 12-9.
145. Mushtaq T, Wales JK, Wright NP. Adrenal insufficiency in phytos-terolaemia. Eur J Endocrinol 2007; 157 Suppl 1: S61-5.
146. Bradford PG, Awad AB. Phytosterols as anticancer compounds. Mol Nutr Food Res 2007; 51: 161-70.
147. Awad AB, Roy R, Fink CS. Beta-sitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells. Oncol Rep 2003; 10: 497-500.
148. Woyengo TA, Ramprasath VR, Jones PJH. Anticancer effects of phytosterols. Eur J Clin Nutr 2009; 63: 813-20.
149. Berges RR, Kassen A, Senge T. Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: an 18-month follow-up. BJU Int 2000; 85: 842-6.
150. Athyros VG, Kakafika AI, Papageorgiou AA, et al. Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors. Nutr Metab Cardiovasc Dis 2011; 21: 213-21.
151. Glueck CJ, Speirs J, Tracy T, Streicher P, Illig E, Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism 1991; 40: 842-8.
152. Matthan NR, Pencina M, LaRocque JM, et al. Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. J Lipid Res 2009; 50: 1927-35.
153. Rajaratnam RA, Gylling H, Miettinen TA. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol 2000; 35: 1185-91.
154. Assmann G, Cullen P, Erbey J, Ramey DR, Kannenberg F, Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Nutr Metab Cardiovasc Dis 2006; 16: 13-21.
155. Silbernagel G, Fauler G, Renner W, et al. The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease. J Lipid Res 2009; 50: 334-41.
156. Silbernagel G, Fauler G, Hoffmann MM, et al. The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality. J Lipid Res 2010; 51: 2384-93.
157. Weingärtner O, Weingärtner N, Scheller B, et al. Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis. Coron Artery Dis 2009; 20: 376-82.
158. Wilund KR, Yu L, Xu F, et al. No association between plasma levels of plant sterols and atherosclerosis in mice and men. Arterio-scler Thromb Vasc Biol 2004; 24: 2326-32.
159. Windler E, Zyriax BC, Kuipers F, Linseisen J, Boeing H. Association of plasma phytosterol concentrations with incident coronary heart disease Data from the CORA study, a case-control study of coronary artery disease in women. Atherosclerosis 2009; 203: 284-90.
160. Pinedo S, Vissers MN, von Bergmann K, et al. Plasma levels of plant sterols and the risk of future coronary artery disease in healthy men and women; the prospective Epi-Norfolk population study. J Lipid Res 2007; 48: 139-44.
161. Fassbender K, Lütjohann D, Dik MG, et al. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk. The LASA study. Atherosclerosis 2008; 196: 283-8.
162. Strandberg TE, Gylling H, Tilvis RS, Miettinen TA. Serum plant and other noncholesterol sterols, cholesterol metabolism and 22-year mortality among middle-aged men. Atherosclerosis 2010; 210: 282-7.
163. Weingärtner O, Lütjohann D, Ji S, et al. Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol 2008; 51: 1553-61.
164. Helske S, Miettinen T, Gylling H, et al. Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves. J Lipid Res 2008; 49: 1511-8.
165. Miettinen TA, Railo M, Lepäntalo M, Gylling H. Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. J Am Coll Cardiol 2005; 45: 1794-801.
166. Plat J, Brzezinka H, Lütjohann D, Mensink RP, von Bergmann K. Oxidized plant sterols in human serum and lipid infusions as measured by combined gas-liquid chromatography-mass spectrometry. J Lipid Res 2001; 42: 2030-8.
167. Salonen JT, Nyyssonen K, Salonen R, et al. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 1997; 95: 840-5.
168. Zieden B, Kaminskas A, Kristenson M, et al. Increased plasma 7-beta-hydroxicholesterol concentrations in a population with a high risk for cardiovascular risk. Arterioscler Thromb Vasc Biol 1999; 19: 967-71.
169. Adcox C, Boyd L, Oehrl L, Allen J, Fenner G. Comparative effects of phytosterol oxides and cholesterol oxides in cultured macro-phage derived cell lines. J Agric Food Chem 2001; 49: 2090-5.
170. Ryan E, Chopra J, McCarthy F, Maguire AR, O'Brien NM. Qualitative and quantitative comparison of the cytotoxic and apoptotic potential of phytosterol oxidation products with their corresponding cholesterol oxidation products. Br J Nutr 2005; 94: 443-51.
171. Moghadhasian MH, McManus BM, Pritchard PH, Frohlich JJ. Tall oil-derived phytosterols reduce atherosclerosis in apoE deficient mice. Arterioscler Thromb Vasc Biol 1997; 17: 119-26.
172. McManus BM, Godin DV, Rodrigues B, Froh-lich JJ. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice. Possible mechanisms of action. Circulation 1999; 99: 1733-9.